

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
I-Rituximab-abbs iyimithi ye-biosimilar esiza ukwelapha iminyango ethile yomdlavuza wegazi kanye nezimo ze-autoimmune ngokugxila kumaseli athile ohlelweni lwakho lomzimba. Le therapy yokufaka igazi isebenza ngokubopha kuphrotheni ebizwa nge-CD20 etholakala kuma-B-cells, okuyiluphi uhlobo lwamaseli amhlophe egazi angaba yinkinga ezifweni ezihlukahlukene.
Cabanga ngayo njengokwelashwa okuqondiwe okusiza umzimba wakho ukuthi usethe kabusha impendulo yawo yokuzivikela lapho ingasebenzi kahle. Ithimba lakho lezempilo lizokuqapha ngokucophelela ngaso sonke isikhathi sokwelashwa ukuze liqinisekise ukuthi uthola ukunakekelwa okungcono kakhulu.
I-Rituximab-abbs iyinguqulo ye-biosimilar yomuthi wokuqala we-rituximab, okusho ukuthi isebenza cishe ngokufana nomuthi obhekiswayo kodwa yenziwa yinkampani ehlukile. Kuyi-monoclonal antibody eqondiswe ngqo kuma-CD20 proteins kuma-B-lymphocytes (uhlobo lwamaseli amhlophe egazi).
Umuthi unikezwa ngokufakwa kwe-IV, ngokuvamile esibhedlela noma esikhungweni sokufaka igazi lapho abasebenzi bezokwelapha bengakuqapha khona eduze. Iyingxenye yeqembu lemithi ebizwa ngokuthi i-immunotherapy, okusho ukuthi isebenza nohlelo lwakho lomzimba kunokuthi ilwe nalo.
Udokotela wakho angase ancome i-rituximab-abbs lapho okunye ukwelashwa kungasebenzi ngokwanele noma njengengxenye yohlelo olubanzi lokwelashwa. Ingxenye ethi "abbs" imane nje ikhomba inguqulo yomkhiqizi ethile yalo muthi oqashelwe kahle.
I-Rituximab-abbs iphatha izimo eziningi ezingathi sína ezihilela ama-B-cells aziphatha ngendlela engavamile emzimbeni wakho. Udokotela wakho uzonquma ukuthi lo muthi ulungele isimo sakho esithile ngokuya ngokuxilongwa kwakho nempilo yonke.
Nawa amanye amazwi amakhulu lo muthi owelapha ngawo:
Kwezinye izimo, udokotela wakho angase futhi acabangele i-rituximab-abbs kwezinye izimo ze-autoimmune lapho ama-B-cells adala izinkinga. Isimo ngasinye sihlukile, futhi uhlelo lwakho lokwelapha luzolungiswa ngokuqondile ezidingweni zakho.
I-Rituximab-abbs isebenza ngokunamathela kuma-CD20 amaprotheni ngaphezulu kwama-B-cells, iwaqophele ukuba abhujiswe amasosha akho omzimba. Le nqubo isiza ukunciphisa inani lama-B-cells anezinkinga abamba iqhaza esimweni sakho.
Lapho umuthi usunamathele kula maseli, kwenzeka izinto eziningana. Amasosha akho omzimba aqaphela amaseli amakwe njengezinto okufanele zihlaselwe futhi aziqede ngezindlela zemvelo. Lokhu kuncipha kwama-B-cells kungasiza ukuthulisa izimpendulo ezingaphezu kwamandla amasosha omzimba noma ukunciphisa inani lamaseli anomdlavuza.
Imiphumela ayisheshi, okuyinto evamile ngokuphelele. Ngokuvamile kuthatha amasonto ambalwa kuya ezinyangeni ukuthi uqaphele ukuthuthuka njengoba amazinga akho e-B-cell ehla kancane kancane futhi isimo sakho siqala ukuphendula ekwelapheni.
Lo muthi uthathwa njengonamandla kakhulu, ngakho-ke ithimba lakho lezempilo lizokuqapha ngokucophelela ngesikhathi sokwelashwa. Amandla e-rituximab-abbs yisizathu esisodwa esenza ukuthi isebenze ezimweni ezinzima, kodwa futhi kusho ukuthi ukuqashwa kwezokwelapha okuseduze kubalulekile.
I-Rituximab-abbs ihlala inikezwa njenge-intravenous (IV) infusion endaweni yezokwelapha, hhayi njengepilisi noma umjovo ongazenzela wona ekhaya. Ithimba lakho lezempilo lizosingatha zonke izici zokulungiselela nokuphatha.
Ngaphambi kokufakelwa kwakho, ngokuvamile uzothola imithi yangaphambi kokwelashwa ukusiza ukuvimbela ukusabela komzimba. Lokhu kungabandakanya ama-antihistamines, i-acetaminophen, noma ama-corticosteroids. Umhlengikazi wakho uzoqala lokhu cishe imizuzu engama-30-60 ngaphambi kokuqala ukufakelwa kwe-rituximab-abbs.
Ukufakelwa kwangempela kuvame ukuthatha amahora amaningana, kuqala kancane futhi kwandisa kancane izinga uma ukubekezelela kahle. Ukufakelwa kwakho kokuqala kuvame ukuthatha isikhathi eside, ngezinye izikhathi amahora ama-4-6, ngenkathi ukufakelwa okulandelayo kungaba kufushane uma ungenazo izindlela zokuphendula.
Akudingeki ukuthi uzile ngaphambi kokwelashwa, kodwa ukudla ukudla okulula ngaphambi kwesikhathi kungakusiza ukuthi uzizwe ukhululekile ngesikhathi senqubo ende yokufakelwa. Ukuhlala unamanzi kahle ezinsukwini eziholela ekwelashweni nakho kuyasiza.
Hlela ukuchitha iningi losuku esikhungweni sokwelashwa, futhi cabanga ngokuletha ukuzijabulisa noma ukuba nomuntu ozohlala nawe ukuze akusekele. Ithimba lakho lezokwelapha lizobheka izimpawu zakho ezibalulekile futhi libheke noma yiziphi izindlela zokuphendula kuyo yonke inqubo.
Ubude bokwelashwa nge-rituximab-abbs buhlukahluka kakhulu ngokuya ngesimo sakho esithile nokuthi usabela kahle kangakanani ekwelashweni. Udokotela wakho uzokwenza isimiso sokwelashwa esenziwe ngendlela oyifisayo esekelwe ezimisweni ezisunguliwe zokuxilongwa kwakho okuthile.
Ngeminye iminyango yegazi efana ne-lymphoma, ungase uthole ukufakelwa kanye ngesonto amasonto ama-4, bese uphumule, noma uzithole njalo ngemva kwamasonto ama-3 imijikelezo eminingana. Isikhathi sokwelashwa esiphelele singahluka kusuka ezinyangeni ezimbalwa kuya ngaphezu konyaka, kuye ngokuthi usabela kanjani kanye nesimiso esithile sokwelashwa.
Uma welashwa i-rheumatoid arthritis, ngokuvamile uzothola ukufakelwa okubili okunikezwa ngemva kwamasonto ama-2. Udokotela wakho angase ancome ukuphinda lo mjikelezo njalo emva kwezinyanga eziyi-6-12 ngokuya ngokuthi izimpawu zakho zithini futhi zibuyela kanjani ngokuhamba kwesikhathi.
Ezimweni ezingavamile zokuzivikela komzimba njenge-GPA noma i-MPA, izinhlelo zokwelapha zivame ukwenziwa ngabanye. Abanye abantu badinga ukufakwa njalo ukuze banakekele, kanti abanye bangase babe nezikhathi ezinde phakathi kokwelashwa uma isimo sabo sesilawulwa.
Udokotela wakho uzohlola njalo impendulo yakho ngokusebenzisa ukuhlolwa kwegazi, izifundo zokuthwebula izithombe, nokuhlola izimpawu. Ngokusekelwe kulezi zinto, bazolungisa umugqa wakho wesikhathi sokwelashwa ukuze bakunike imiphumela engcono kakhulu ngenkathi benciphisa ukuchayeka okungadingekile emithini.
Njengayo yonke imithi enamandla, i-rituximab-abbs ingabangela imiphumela emibi, nakuba abantu abaningi beyibekezelela kahle ngaphansi kokuqondiswa okufanele kwezokwelapha. Ukuqonda okufanele ukukulindela kungakusiza ukuthi uzizwe ulungile futhi wazi ukuthi ungaxhumana nini nethimba lakho lezempilo.
Imiphumela emibi evame kakhulu ongase uyithole ihlanganisa:
Lezi zimo zivame ukulawuleka ngemithi efanele ngaphambi kokwelashwa nokunakekelwa okusekelayo. Ithimba lakho lezokwelapha liyazi ukuthi lingazivimbela futhi lilaphe kanjani iningi lale miphumela emibi ngempumelelo.
Imiphumela emibi engathi sína kodwa engavamile idinga ukunakekelwa kwezokwelapha ngokushesha:
Izinkinga ezingavamile kodwa ezinzima zingabandakanya i-progressive multifocal leukoencephalopathy (PML), ukutheleleka kobuchopho, kanye ne-tumor lysis syndrome ezigulini ezinomdlavuza. Nakuba lokhu kungavamile, ithimba lakho lezempilo lizokuqapha ngokucophelela ukuze libone izimpawu zakuqala futhi lithathe izinyathelo zokuvimbela uma kungenzeka.
I-Rituximab-abbs ayifanele wonke umuntu, futhi udokotela wakho uzohlola ngokucophelela umlando wakho wezokwelapha kanye nesimo sakho samanje sempilo ngaphambi kokuncoma lokhu kwelashwa. Izimo ezithile zenza lo muthi ube yingozi kakhulu noma ube yingozi.
Akufanele uthole i-rituximab-abbs uma une:
Udokotela wakho uzosebenzisa ukuqapha okwengeziwe futhi angakugwema lokhu kwelashwa uma unezimo ezithile ezenyusa ingozi yakho yezinkinga.
Izimo ezidinga ukucatshangelwa ngokucophelela zihlanganisa:
Uma ukhulelwe noma uhlela ukukhulelwa, i-rituximab-abbs ingalimaza ingane yakho esakhula. Udokotela wakho uzoxoxa ngezindlela zokwelapha ezingezinye noma akusize ukuthi uhlele isikhathi sokwelashwa ngesikhathi sokukhulelwa. Umuthi ungangena obisini lwebele, ngakho-ke ukuncelisa akukhuthazwa ngesikhathi sokwelashwa.
I-Rituximab-abbs ithengiswa ngaphansi kwegama lomkhiqizo elithi Truxima e-United States. Le nguqulo ye-biosimilar iqukethe isithako esifanayo esisebenzayo njenge-rituximab yasekuqaleni (Rituxan) kodwa yenziwa yinkampani ehlukile yezemithi.
Ukuqokwa okuthi "abbs" kubhekisela esijobelelweni esithile somkhiqizi, esisiza ukuhlukanisa le biosimilar kwezinye izinhlobo ze-rituximab ezingase zitholakale. Ikhemisi lakho nethimba lezokunakekelwa kwezempilo lizoqinisekisa ukuthi uthola ifomula efanele ebekwe ngudokotela wakho.
Noma ngabe uthola i-Truxima noma enye inguqulo ye-rituximab, imiphumela yokwelapha kufanele ilingane. Udokotela wakho uzokhetha inketho efanelekayo futhi etholakalayo ngokususelwa ekuhlinzekweni komshuwalense wakho nakuzintandokazi zesikhungo sokwelashwa.
Ukwelashwa okuningana okuhlukile kungatholakala ngokuya ngesimo sakho esithile, yize udokotela wakho ezoqoka inketho engcono kakhulu ngokususelwa ezimweni zakho ngazinye nomlando wezokwelapha.
Ngeminye iminyango yegazi, ezinye izindlela zingabandakanya:
Ngezimo ze-autoimmune ezinjenge-rheumatoid arthritis, udokotela wakho angacabangela ezinye izinketho uma i-rituximab-abbs ingakulungele.
Lezi zindlela ezingezinye zingabandakanya:
Ukukhetha okunye kuncike ezintweni eziningi ezihlanganisa ukuxilongwa kwakho okuqondile, ukwelashwa kwangaphambilini, ezinye izimo zezokwelapha, nezintandokazi zakho. Ithimba lakho lokunakekelwa kwezempilo lizosebenza nawe ukuthola inketho yokwelashwa efaneleka kakhulu uma i-rituximab-abbs ingeyona inketho efanele.
I-Rituximab-abbs (Truxima) ne-rituximab yasekuqaleni (Rituxan) zithathwa njengezilingana ngokwelapha, okusho ukuthi kufanele zisebenze kahle ngokulinganayo ekwelapheni isimo sakho. Umehluko omkhulu ulele ekukhiqizeni nasezindlekweni kunokusebenza kahle.
Zombili lezi zithako ziqukethe isithako esifanayo esisebenzayo futhi zisebenza ngezindlela ezifanayo emzimbeni wakho. Izifundo zemitholampilo zikhombisile ukuthi i-biosimilar rituximab ikhiqiza imiphumela yokwelashwa efanayo, amaphrofayili okuphepha, namaphethini emiphumela emibi uma kuqhathaniswa nefomula yasekuqaleni.
Izinzuzo eziyinhloko ze-rituximab-abbs zivame ukuba yizomnotho. Imithi ye-Biosimilar ngokuvamile ibiza ngaphansi kwemikhiqizo yabo eyinkomba, okwenza ukwelashwa kufinyeleleke kalula futhi kunciphise izindleko zokunakekelwa kwezempilo. Umshwalense wakho ungase futhi ukhethe ukumboza inguqulo ye-biosimilar.
Ngokombono wokwelashwa, akufanele ulindele noma yimuphi umehluko ekusebenzeni kahle komuthi noma ukuthi umzimba wakho usabela kanjani kuwo. Udokotela wakho uzokhetha phakathi kwalezi ezimbili ngokusekelwe ekutholakaleni, ukucatshangelwa kwezindleko, nezintandokazi zesikhungo sakho sokwelashwa kunokuba umehluko ekusebenzeni kokwelapha.
Uma ngabe ngaphambilini uthole i-rituximab yasekuqaleni futhi ushintshela kunguqulo ye-biosimilar, lokhu kuguquka kuthathwa njengokuphephile futhi akufanele kuthinte imiphumela yakho yokwelashwa. Ithimba lakho lokunakekelwa kwezempilo lizokuqapha ngokucophelela kungakhathaliseki ukuthi iyiphi inguqulo oyitholayo.
I-Rituximab-abbs idinga ukuhlolwa ngokucophelela kubantu abanezimo zenhliziyo, njengoba umuthi ngezinye izikhathi ungathinta ukushaya kwenhliziyo nomfutho wegazi ngesikhathi sokufakwa. Udokotela wakho wenhliziyo kanye nodokotela wakho we-oncologist noma we-rheumatologist bazosebenzisana ukuthola ukuthi izinzuzo zidlula izingozi esimweni sakho esithile.
Uma unesifo senhliziyo, ithimba lakho lezokwelapha lizothatha izinyathelo zokuphepha ezengeziwe ngesikhathi sokwelashwa. Lokhu kungabandakanya ukuqapha njalo ukushaya kwenhliziyo yakho, ukulungisa izinga lokufakwa, noma ukuhlinzeka ngemithi eyengeziwe yokusekela uhlelo lwakho lwe-cardiovascular ngesikhathi sokwelashwa.
Abantu abaningi abanezimo zenhliziyo eziphakathi nendawo bangathola i-rituximab-abbs ngokuphepha ngokuqapha okufanele. Kodwa-ke, uma unenhliziyo ehlulekayo noma ukuhlaselwa yinhliziyo kwakamuva, udokotela wakho angase ancome ezinye izindlela zokwelapha ezingabangeli ingozi encane ye-cardiovascular.
Njengoba i-rituximab-abbs inikezwa kuphela ezikhungweni zezokwelapha ochwepheshe bezempilo abaqeqeshiwe, ukweqisa ngengozi akunakwenzeka. Umuthi ubhalwa ngokucophelela ngokusekelwe esisindweni somzimba wakho kanye nesimo sezokwelapha, bese uhlolwa kabili ngaphambi kokuphathwa.
Uma ukhathazekile ngokuthola umuthi omningi ngesikhathi sokufakwa kwakho, unganqikazi ukukhuluma nomhlengikazi wakho noma udokotela ngokushesha. Bangaqinisekisa umthamo ofanele futhi babhekane nanoma yikuphi ukukhathazeka ongase ube nakho mayelana nokwelashwa kwakho.
Esimeni esingavamile sokweqisa, ithimba lakho lezokwelapha linganikeza ukunakekelwa okusekelayo futhi likuqaphe eduze nganoma yimaphi imiphumela emibi eyengeziwe. Akukho umuthi oqondile we-rituximab-abbs, ngakho ukwelashwa kugxila ekuphatheni noma yiziphi izimpawu ezingase zivele.
Uma uphuthelwa ukufakwa kwe-rituximab-abbs okuhleliwe, xhumana nethimba lakho lezempilo ngokushesha ngangokunokwenzeka ukuze ulungise kabusha. Ungazami ukwenza isinxephezelo ngomthamo ophuthelwe ngokwenza kabili ekwelashweni kwakho okulandelayo, ngoba lokhu kungandisa ingozi yakho yemiphumela emibi.
Udkt wakho uzonquma indlela engcono yokubuyisela isimiso sakho sokwelashwa endleleni. Lokhu kungase kuhlanganise ukuhlela kabusha umthamo wakho ophuthelwe noma ukulungisa lonke uhlu lwakho lwezokwelashwa kuye ngokuthi ukubambezeleka kwakude kangakanani nokuthi ukuphi emjikelezweni wakho wokwelashwa.
Ukuphuthelwa ukufakwa okukodwa ngokuvamile ngeke kube nomthelela omkhulu emiphumeleni yakho yokwelashwa iyonke, ikakhulukazi uma ungahlela kabusha ngesikhathi esifanele. Kodwa-ke, kubalulekile ukugcina isimiso sakho sokwelashwa ngokusondela ngangokunokwenzeka ukuze uthole imiphumela engcono.
Isinqumo sokuyeka i-rituximab-abbs kufanele senziwe ngaso sonke isikhathi ngokubonisana nethimba lakho lezempilo, hhayi wedwa. Udkt wakho uzosekela lesi sinqumo ekutheni isimo sakho siphendula kahle kangakanani ekwelashweni kanye nesimo sakho sempilo esiphelele.
Ukwelashwa komdlavuza, ngokuvamile uzoqeda inani elinqunywe ngaphambilini lemijikelezo ngokusekelwe kumaphrothokholi asunguliwe ohlobo lwakho oluthile lomdlavuza. Udkt wakho uzohlola impendulo yakho ngokuskena, ukuhlolwa kwegazi, nokuhlolwa komzimba ngaphambi kokunquma ukuthi udinga ukwelashwa okwengeziwe.
Uma uthola i-rituximab-abbs ngezifo ze-autoimmune, iphuzu lokuyeka lingase lingachazwanga kahle. Abanye abantu bafinyelela ekuthethelelweni okuhlala isikhathi eside ngemva kochungechunge lokwelashwa, kanti abanye bangase badinge ukufakwa kwesondlo ngezikhathi ezithile ukuze bagcine isimo sabo silawulwa.
Ungalokothi uyeke ukwelashwa ngaphambi kwesikhathi ngoba uzizwa ungcono noma unomuzwa wemiphumela emibi ngaphandle kokuxoxa ngakho nodokotela wakho kuqala. Bangakusiza ukuthi ulinganise izinzuzo nezingozi zokuqhubeka nokumisa ukwelashwa ngokusekelwe esimweni sakho.
I-Rituximab-abbs ithinta ikhono lomzimba wakho lokuzivikela ekuphenduleni imigomo, ngakho-ke isikhathi nohlobo lwemigomo kudinga ukuhlelwa ngokucophelela nethimba lakho labanakekeli bezempilo. Imigomo ephilayo kufanele igwenywe ngokuphelele ngesikhathi sokwelashwa kanye nezinyanga eziningana ngemuva.
Udkt wakho ngokuvamile uzoncoma ukuqeda noma yimiphi imigomo edingekayo ngaphambi kokuqala ukwelashwa nge-rituximab-abbs uma kungenzeka. Lokhu kufaka phakathi imigomo ejwayelekile efana nemijovo yomkhuhlane, kanye nanoma iyiphi imigomo yokuhamba ongase uyidinge.
Uma udinga imigomo ngesikhathi sokwelashwa, ithimba lakho labanakekeli bezempilo lizokhetha imigomo engasebenzi (ebulaliwe) kunokuba izinhlobo eziphilayo. Kodwa-ke, le migomo ingase inganikezi izinga elifanayo lokuvikela njengoba izokwenza lapho umzimba wakho wokuzivikela usebenza ngokujwayelekile, ngakho-ke izinyathelo ezengeziwe zokuzivikela ekuthelelekeni zibaluleke nakakhulu.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.